Impact on parents of HLA-DQ2/DQ8 genotyping in healthy children from coeliac families

Margreet M S Wessels, Sabine L Vriezinga, Sybille Koletzko, Katharina Werkstetter, Gemma Castillejo-De Villasante, Raanan Shamir, Corina Hartman, Hein Putter, Sylvia M van der Pal, Cisca Wijmenga, Enzo Bravi, M Luisa Mearin, PreventCD Study Group, Margreet M S Wessels, Sabine L Vriezinga, Sybille Koletzko, Katharina Werkstetter, Gemma Castillejo-De Villasante, Raanan Shamir, Corina Hartman, Hein Putter, Sylvia M van der Pal, Cisca Wijmenga, Enzo Bravi, M Luisa Mearin, PreventCD Study Group

Abstract

Due to the association of coeliac disease and HLA-specificities DQ2 and DQ8, HLA-typing can be used for risk determination of the disease. This study was designed to evaluate the knowledge of parents from coeliac families regarding HLA-typing and the impact of HLA-typing on the perception of the health of their children. A structured questionnaire was sent to the Dutch, Spanish and German parents participating with their child in the European PreventCD study on disease prevention in high-risk families, addressing parents' understanding of and attitude towards HLA-typing, distress related to HLA-typing and perceived health and health-related quality of life of their children. Sixty-eight percent of parents of 515 children returned the questionnaires, with 85% of children being DQ2/DQ8 positive. The majority of all parents answered the questions on knowledge correctly. Forty-eight percent of parents of DQ2/DQ8-negative children thought their child could develop coeliac disease. More distress was reported by parents of DQ2/DQ8-positive children (P<0.001). All parents showed few regrets and would repeat HLA-typing in future children. Perceived health and health-related quality of life were similar. In conclusion, we can say that misinterpretation of DQ2/DQ8-negative results by parents is frequent. DQ2/DQ8-positive results do not affect perceived health and health-related quality of life of children but may cause temporary negative feelings among parents. Parents of coeliac families seem to support HLA-typing.

Figures

Figure 1
Figure 1
Parental assessment of risk of developing coeliac disease in their child according to HLA-typing results.

References

    1. Mearin ML. Celiac disease among children and adolescents. Curr Probl Pediatr Adolesc Health Care. 2007;37:86–105.
    1. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731–1743.
    1. Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology. 2005;128 (4 Suppl 1:S38–S46.
    1. Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther. 2008;28:1042–1066.
    1. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169:345–350.
    1. Monsuur AJ, de Bakker PI, Zhernakova A, et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS One. 2008;3:e2270.
    1. van Belzen MJ, Koeleman BP, Crusius JB, et al. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun. 2004;5:215–220.
    1. Karell K, Louka AS, Moodie SJ, et al. Hla types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the european genetics cluster on celiac disease. Hum Immunol. 2003;64:469–477.
    1. Bourgey M, Calcagno G, Tinto N, et al. HLA related genetic risk for coeliac disease. Gut. 2007;56:1054–1059.
    1. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.
    1. van Doorn RK, Winkler LM, Zwinderman KH, Mearin ML, Koopman HM. CDDUX: a disease-specific health-related quality-of-life questionnaire for children with celiac disease. J Pediatr Gastroenterol Nutr. 2008;47:147–152.
    1. Rosen A, Ivarsson A, Nordyke K, et al. Balancing health benefits and social sacrifices: a qualitative study of how screening-detected celiac disease impacts adolescents' quality of life. BMC Pediatr. 2011;11:32.
    1. Tercyak KP, Hensley AS, Emmons KM, Lipkus IM, Wilfond BS, McBride CM. Parents' attitudes toward pediatric genetic testing for common disease risk. Pediatrics. 2011;127:e1288–e1295.
    1. Kerruish NJ, Campbell-Stokes PL, Gray A, Merriman TR, Robertson SP, Taylor BJ. Maternal psychological reaction to newborn genetic screening for type 1 diabetes. Pediatrics. 2007;120:e324–e335.
    1. Hogen Esch CE, Rosen A, Auricchio R, et al. The PreventCD Study design: towards new strategies for the prevention of coeliac disease. Eur J Gastroenterol Hepatol. 2010;22:1424–1430.
    1. Plass AMC, Hemminga M, Westerman M, Cornel MC. Ervaringen van ouders rond de uitslag "drager van sikkelcelziekte" van hun pasgeboren baby naar aanleiding van de per 1 januari 2007 uitgebreide hielprik. TSG. 2009;87:118–125.
    1. Vernooij-van Langen AM, Loeber JG, Elvers B, et al. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study. Thorax. 2012;67:289–295.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.
    1. Fekkes M, Theunissen NC, Brugman E, et al. Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res. 2000;9:961–972.
    1. Fekkes MBJ.TAPQOL Manual. Leiden Center for Child Health and Pediatrics LUMC-TNO. 2004. Ref Type: Online Source.
    1. Grosfeld FJ, Beemer FA, Lips CJ, Hendriks KS, ten Kroode HF. Parents' responses to disclosure of genetic test results of their children. Am J Med Genet. 2000;94:316–323.
    1. Tibben A, Frets PG, van de Kamp JJ, et al. On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am J Med Genet. 1993;48:103–111.
    1. Michie S, Smith JA, Senior V, Marteau TM. Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet A. 2003;119A:340–347.
    1. Eiser JR. Communication and interpretation of risk. Br Med Bull. 1998;54:779–790.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다